Exelixis (EXEL) EBIT Margin (2010 - 2026)
Exelixis' (EXEL) quarterly EBIT Margin came in at 41.15% in Q2 2026, up 751.0% year-on-year from 4.84% in Q2 2025, and up 4.73% quarter-over-quarter from 39.29% in Q1 2026.
Exelixis (EXEL) EBIT Margin (2010 - 2026) Analysis & Trends
Exelixis' EBIT Margin history runs 17 years deep, the most recent figure standing at 41.15% for Q2 2026.
- On a quarterly basis, EBIT Margin rose 751.0% year-over-year to 41.15% in Q2 2026; TTM through Apr 2026 was 39.43%, a 628.0% increase from a year earlier, with the FY2026 full-year figure at 37.59%, up 971.0% from the prior year.
- EBIT Margin climbed to 41.15% in Q2 2026 per EXEL's latest filing, from 39.29% in the prior quarter.
- Across five years, EBIT Margin topped out at 43.3% in Q2 2024 and bottomed at 11.34% in Q4 2022.
- The 5-year median for EBIT Margin is 23.38% (2022), against an average of 22.62%.
- Across the five-year window, EBIT Margin sank 2379 bps in 2023 and surged 2895 bps in 2024, its largest moves.
- Year by year, EBIT Margin stood at 11.34% in 2022, then jumped by 250 bps to 17.05% in 2023, then jumped by 48 bps to 25.22% in 2024, then jumped by 57 bps to 39.57% in 2025, then grew by 4 bps to 41.15% in 2026.
- Per Business Quant, the three latest EXEL EBIT Margin figures stand at 41.15% (Q2 2026), 39.29% (Q1 2026), and 39.57% (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 41.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 41.15% |
| Jan 2, 2026 | 39.29% |
| Oct 3, 2025 | 39.57% |
| Jul 4, 2025 | 37.58% |
| Apr 4, 2025 | 33.64% |
| Jan 3, 2025 | 28.80% |
| Sep 27, 2024 | 25.22% |
| Jun 28, 2024 | 43.30% |
| Mar 29, 2024 | 6.93% |
| Dec 29, 2023 | 17.05% |
| Sep 29, 2023 | -3.73% |
| Jun 30, 2023 | 16.57% |
| Mar 31, 2023 | 7.05% |
| Dec 30, 2022 | -11.34% |
| Sep 30, 2022 | 20.06% |
| Jul 1, 2022 | 19.96% |
| Apr 1, 2022 | 23.38% |
| Oct 1, 2021 | 15.72% |
| Jul 2, 2021 | 31.94% |
| Apr 2, 2021 | -1.70% |